Novel TRKB Agonists Activate TRKB and Downstream ERK and AKT Signaling
Dr. Ya-Jen Chiu from the Department of Life Science at National Taiwan Normal University in Taipei, discusses a paper she co-authored that was published by Aging (Aging-US) in Volume 14, Issue 18, “Novel TRKB agonists activate TRKB and downstream ERK and AKT signaling to protect Aβ-GFP SH-SY5Y cells against Aβ toxicity.”
